Announcement
15 April 2015
At the company’s Annual General Meeting held today, the following resolutions were passed:
- The Annual Report for 2014 was approved
- The Board of Directors' proposal regarding the transfer of the loss for 2014 to retained earnings was adopted
- The Board of Directors was re-elected and thus still consists of Karin Garre (Chairman), Allan Andersen and Christian Lundgren
- PricewaterhouseCoopers was re-elected as the company’s auditor
- The Board of Directors' proposal that new shares issued by the company shall be shares registered by name was adopted
- The general meeting authorised the Board of Directors to prolong the authorisation to increase the company's share capital by up to a total of DKK 4,875,000 (4,875,000 shares of DKK 1 each) until 15 April 2020
- The general meeting authorised the Board of Directors to purchase own shares with a total nominal value of up to DKK 2,455,394 (corresponding to 10% of the company's present share capital) in the period until the next Annual General Meeting
- The Board of Directors' proposed fees to the Board of Directors for 2015 were adopted.
Karin Garre Allan Andersen
Chairman of the Board of Directors CEO
Contact
Allan Andersen, CEO, mobile phone +45 4016 3864.
About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S.
